Dicliz Plus (Doxylamine Succinate + Pyridoxine Hydrochloride)
Therapeutic Group : Antiemetic
Presentation:
Dicliz Plus Tablet: Each film coated delayed release tablet contains Doxylamine Succinate USP 10 mg & Pyridoxine Hydrochloride BP 10 mg.
Indications:
Dicliz Plus is indicated for the treatment of nausea and vomiting during pregnancy.
Dosage & Administration:
Take two tablets daily before bedtime in an empty stomach. If symptoms are not adequately controlled, the dose can be increased to four tablets daily (one in the morning, one mid-afternoon and two at bedtime).
Contrainidications:
This combination is contraindicated in women with known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride, Monoamine oxidase (MAO) inhibitors or any inactive ingredient in the formulation.
Warning & Precautions:
This combination may cause somnolence due to the anticholinergic properties of doxylamine succinate, an antihistamine. Women should avoid engaging in activities requiring complete mental alertness, such as driving or operating heavy machinery. Use of this drug is not recommended if a woman is concurrently using central nervous system (CNS) depressants including alcohol.
Side effects:
The most common side effect may include somnolence.
Drug interaction:
Use of this drug is contraindicated in women who are taking monoamine oxidase inhibitors (MAOIs), which prolong and intensify the anticholinergic effects of antihistamines. Concurrent use of alcohol and other CNS depressants (such as hypnotic sedatives and tranquilizers) with this combination is not recommended.
Use in special groups:
Use in pregnancy: Both Doxylamine and Pyridoxine are pregnancy category A drugs. Therefore, Dicliz Plus can be given to pregnant women safely.
Use in nursing mothers: Both Doxylamine and Pyridoxine are excreted into breast milk. Therefore, caution should be exercised while breast feeding.
Packing:
Dicliz Plus Tablet: Each box contains 50 tablets in alu-alu blister pack.
